RE: abacus4 Oct 2021 16:00
thanks 121
I do find the potential here difficult to grasp.
Thats an interesting comment 'GlobalData predicts the ALL market will grow from $1.46 billion in 2019 to $2.26 billion in 2029 across eight major markets – the US, France, Germany, Italy, Spain, the UK, Japan, and China'.
Do we know the size of the market for HEMO CAR T (treating AML) - it must be beyond this potential $2.26 billion? The broker note indicates Yescarta revenue of $456m and Kymriah at £278m in 2019.
CDs